MUNICH, July 3, 2025 /PRNewswire/ -- Novogene Europe announces the installation of its fifth Illumina NovaSeq X Plus sequencing system, expanding high-throughput sequencing capacity to meet ...

China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war.

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

Business Strategy and Market Position Illumina's strategy revolves around maintaining its dominant position in the sequencing market while adapting to evolving customer needs and competitive ...

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...

Business Strategy and Outlook Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications.

Illumina, Inc. on Monday announced that it will present updates on several key innovations in whole-genome sequencing, proteomics, and single-cell technology at the American Society of Human ...